Cargando…
Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis
Schistosomiasis is a neglected tropical disease affecting more than 200 million people worldwide. Chemotherapy relies on one single drug, praziquantel, which is safe but ineffective at killing larval stages of this parasite. Furthermore, concerns have been expressed about the rise in resistance agai...
Autores principales: | Pereira Moreira, Bernardo, Weber, Michael H. W., Haeberlein, Simone, Mokosch, Annika S., Spengler, Bernhard, Grevelding, Christoph G., Falcone, Franco H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879451/ https://www.ncbi.nlm.nih.gov/pubmed/35209202 http://dx.doi.org/10.3390/molecules27041414 |
Ejemplares similares
-
High-resolution AP-SMALDI MSI as a tool for drug imaging in Schistosoma mansoni
por: Mokosch, Annika S., et al.
Publicado: (2021) -
Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
por: Gouveia, Maria João, et al.
Publicado: (2018) -
Spatial visualization of drug uptake and distribution in Fasciola hepatica using high-resolution AP-SMALDI mass spectrometry imaging
por: Morawietz, Carolin M., et al.
Publicado: (2022) -
Targeting Kinases in Fasciola hepatica: Anthelminthic Effects and Tissue Distribution of Selected Kinase Inhibitors
por: Morawietz, Carolin M., et al.
Publicado: (2020) -
New opportunities for kinase drug repurposing and target discovery
por: Knapp, Stefan
Publicado: (2018)